Open Text is upgraded to 'buy,' while JDSU is downgraded to 'neutral.'
Some of the biggest and highest-yielding drug stocks are declining near attractive buy levels.
Strong growth in 2012 will be driven by its infrastructure businesses and a good backlog of orders.
Not the typical turnaround pick, this company has a problem with investor perceptions.
However you slice it, J&J's prospect of earnings growth looks bleak as economic and competitive 'headwinds' continue.
For income investors with a long-term horizon, here are 10 favorite dividend-paying blue chips.
Here are a few of the top picks from one of the best defensive investing gurus out there.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Internet and social-media stocks are flying high again, and exchange-traded funds in the sector are outperforming the market.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The government's health care portal stumbled badly out of the gate 2 months ago, and it's still far from perfect.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.